Completed PHASE4 INTERVENTIONAL NCT00199056

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)

Multicenter Trial for Treatment of Acute Lymphocytic Leukemia in Adults (Pilot Study 06/99)

Sponsor: Goethe University

Conditions Adult Acute Lymphocytic Leukemia

Interventions 6-Mercaptopurine Adriamycin Asparaginase CNS irradiation Cyclophosphamide Cytarabine Daunorubicin Dexamethasone / Prednisolone Fludarabine G-CSF Idarubicin Ifosfamide Mediastinal irradiation (if residual tumor) Methotrexate Thioguanine VM26 VP16 Vincristine / Vindesine stem cell transplantation

Updated 6 times since 2017 Last updated: Mar 16, 2023 Started: Oct 31, 1999 Primary completion: Nov 30, 2003 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Adult Acute Lymphocytic Leukemia and is currently completed. Goethe University leads this study, which shows 6 recorded versions since 1999 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2023 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Apr 2023 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Goethe University

Data source: Goethe University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Frankfurt, Germany